Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Supply Agreements
Manufacturing
AstraZeneca extends Niowave radioisotope supply deal by 10 years
AstraZeneca extended its supply deal with Niowave by 10 years for the delivery of Actinium-225 to develop targeted cancer treatments.
Joseph Keenan
Dec 23, 2025 7:47am
Ratio, Ionetix ink separate radiopharmaceutical isotope deals
Jun 23, 2025 11:08am
Canada buys an initial 500K bird flu vaccine doses from GSK
Feb 20, 2025 2:00pm
Novavax coughs up $123.8M to settle UK COVID vaccine dispute
Nov 6, 2024 10:27am
Sanofi taps Minapharm for anticoagulant production in Egypt
Dec 11, 2023 10:45am
AbbVie in line for big payout over breached Lupron supply deal
Sep 7, 2023 9:48am